References
- Kao LW, Furbee RB. Drug-induced q-T prolongation. Med Clin North Am 2005; 89:1125–1144.
- Li EC, Esterly JS, Pohl S, Scott SD, McBride BF. Drug-induced QT-interval prolongation: considerations for clinicians. Pharmacotherapy 2010; 30:684–701.
- Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American heart association and the American college of cardiology foundation. Circulation 2010; 121:1047–1060.
- Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/ American heart association task force and the European society of cardiology comittee. Circulation 2006; 114:e385–484.
- Manini AF, Stimmel B, Vlahov D. Racial susceptibility for QT prolongation in acute drug overdoses. J Electrocardiol 2014; 47:244–250.
- Letsas KP, Tsikrikas S. Drug-induced proarrhythmia : QT interval prolongation and torsades de pointes. Hospital Chronicles 2011; 6:118–122.
- Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother 2003; 37:999–1002.
- Chan A, Isbister GK, Kirkpatrick CMJ, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007; 100:609–615.
- Isbister GK, Balit CR, Macleod D, Duffull SB. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes. J Clin Psychopharmacol 2010; 30:391–395.
- American College of Medical Toxicology National Journal Club. Am Coll Med Toxicol 2013. Available at: www.acmt.net. Accessed September 10, 2013.
- Chiladakis J, Kalogeropoulos A, Zagkli F, Koutsogiannis N, Chouchoulis K, Alexopoulos D. Predicting torsade de pointes in acquired long QT syndrome: Optimal identification of critical QT interval prolongation. Cardiology 2012; 122:3–11.
- Indik JH, Pearson EC, Fried K, Woosley RL. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval. Heart Rhythm 2006; 3:1003–1007.
- Ehrlich JR. Choosing tools for QT correction. Heart Rhythm 2006; 3:1008–1009.
- Chiladakis J, Kalogeropoulos A, Arvanitis P, Koutsogiannis N, Zagli F, Alexopoulos D. Preferred QT correction formula for the assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol 2010; 21:905–913.
- Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988; 77:392–397.
- Deal N, Ahn J, Wang E. Focus on: Transcutaneous and transvenous cardiac pacing. ACEP News 2011. Available at: http://www.acep.org/Content.aspx?id = 80813. Accessed June 29, 2014.